Holdings
Sectoral Asset Management Inc
As of Sep 30, 2026, Sectoral Asset Management Inc reported 71 positions worth US$152M. Largest: Apnimed, Inc., Contineum Therapeutics, Inc. and Shoulder Innovations, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Apnimed, Inc. | 942K | US$20.6M | new | Sep 30, 2026 |
| Contineum Therapeutics, Inc. | 690K | US$9.25M | −38,000 | Sep 30, 2026 |
| Shoulder Innovations, Inc. | 430K | US$8.13M | +13 | Sep 30, 2026 |
| Eli Lilly and Company | 6,664 | US$7.71M | +310 | Sep 30, 2026 |
| Johnson & Johnson | 22,758 | US$6.02M | +4,540 | Sep 30, 2026 |
| Vertex Pharmaceuticals Incorporated | 7,532 | US$3.94M | +2,100 | Sep 30, 2026 |
| Gilead Sciences, Inc. | 24,655 | US$3.67M | +4,035 | Sep 30, 2026 |
| Amgen Inc. | 7,860 | US$3.31M | −1,350 | Sep 30, 2026 |
| AbbVie Inc. | 12,300 | US$3.22M | +100 | Sep 30, 2026 |
| DexCom, Inc. | 37,231 | US$3.21M | −13,525 | Sep 30, 2026 |